Skip to main content
. 2018 Nov 30;10(12):678. doi: 10.3390/v10120678

Figure 4.

Figure 4

Structure activity relationship (SAR) of diarylquinoline compounds against EBOV (A) Summary of the SAR analysis the diarylquinoline compounds as Ebola virus entry inhibitors. (B,C) Predicted binding mode of SYL1712 with Ebola glycoprotein by molecular docking (PDB code: 5JQ7). (B) Superposition of SYL1712 (cyan) with toremifene (pink) shows similar binding orientations at the interface between GP1 and GP2; (C) SYL1712 (cyan) forms both hydrophobic interactions (V66, Y517, L558, L184 and L186) and electrostatic interactions (D522) with EBOV GP (C).